Drug Shortage Report for ARSENIC TRIOXIDE FOR INJECTION
| Report ID | 235163 |
| Drug Identification Number | 02492768 |
| Brand name | ARSENIC TRIOXIDE FOR INJECTION |
| Common or Proper name | ARSENIC TRIOXIDE FOR INJECTION |
| Company Name | STERIMAX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ARSENIC TRIOXIDE |
| Strength(s) | 1MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | PACK OF 10 VIALS |
| Anatomical Therapeutical Chemical (ATC) code | L01XX |
| Anatomical Therapeutical Chemical (ATC) description | OTHER ANTINEOPLASTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-08-31 |
| Actual start date | |
| Estimated end date | 2026-01-16 |
| Actual end date | 2026-01-20 |
| Shortage status | Resolved |
| Updated date | 2026-03-17 |
| Company comments | New product code is now available. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
| Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2024-08-13 | English | Compare |